Form
Powder
Appearance
Browncolorcrystallinepowder
Source
Synthetic
ImpurityProfile
Reportsingleimpurity
WaterContent(KarlFisher)
Reportresults
Assay
(HPLC)Reportresults
Cefpodoximesodiumsaltisathirdgenerationcephalosporinβ-lactamantibiotic.
TOKU-Eoffersthreeformsofcefpodoxime:cefpodoximeproxetil(C015),cefpodoximesodiumsalt(C096),andcefpodoximefreeacid(C016).AllformsaresolubleinDMSO(dimethylsulfoxide).
Almetal.usedcefpodoximefromTOKU-EagainstEscherichiacoliNDMisolatesinmicrodilutionMICassays."CharacterizationofEscherichiacoliNDMisolateswithdecreasedsusceptibilitytoaztreonam/avibactam:roleofanovelinsertioninPBP3."
82619-04-3
C15H16N5NaO6S2
449.44
Likeβ-lactams,cephalosporinsinterferewithPBP(penicillinbindingprotein)activityinvolvedinthefinalphaseofpeptidoglycansynthesis.PBP’sareenzymeswhichcatalyzeapentaglycinecrosslinkbetweenalanineandlysineresiduesprovidingadditionalstrengthtothecellwall.Withoutapentaglycinecrosslink,theintegrityofthecellwallisseverelycompromisedandultimatelyleadstocelllysisanddeath.Resistancetocephalosporinsiscommonlyduetocellscontainingplasmidencodedβ-lactamases.However,likemanycephalosporins,cefpodoximeisstableinthepresenceofβ-lactamases.
-20°C,storeprotectedfromlight.
2941.90.5000
Cefpodoximesodiumsaltisabroadspectrumantibioticwhichtargetsawidevarietyofgrampositiveandgramnegativebacteriaespeciallythosewhichcauseotitismediaandpharyngitis.
Powder
Browncolorcrystallinepowder
Synthetic
Reportsingleimpurity
Reportresults
(HPLC)Reportresults